From the total of 58 selected cases that fit the selection criteria, a total of eight tumors (13.7%) harbored the IDH R132H mutation and were hence reclassified as diffuse astrocytoma IDH-mutant, WHO CNS grade 4 (Figure 1). This evidence concerns the gene IDH1 and diffuse astrocytoma.